top of page

Retatrutide (Compounded)

$150/week

Retatrutide (Compounded)

Delivered to your home

  • Class: Triple Agonist – GLP-1 + GIP + Glucagon Receptors

  • How it works: Combines the appetite-suppressing effects of GLP-1 and GIP with glucagon receptor stimulation to increase energy expenditure and fat loss.

  • Typical dosing (in trials):

    • Range: 1.5 mg to 12 mg weekly (titrated slowly over 20+ weeks)

    • Optimal target doses under investigation

  • Status: Not yet FDA-approved (expected in late 2025–2026)

  • Potential benefits: Up to 24% weight loss in trials, improved liver and metabolic markers

  • Administration: Once-weekly injection

-------------------------------------     START YOUR JOURNEY     ------------------------------------- 

Contact
818-823-0263
Info@MeltMedical.com
Follow Us 
  • Facebook
  • Instagram

MEDICAL DISCLAIMER

The information on this site does not create a doctor-patient relationship and is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images and information, contained on or available through this web site is for general information purposes only. • Melt Medical Inc.  • All Rights Reserved

©2023 by MeltMedical.com. 

bottom of page